Created at 10:59 p.m. Feb, 13, 2026
Author: mangosteen_alibaba
Co-authors: mitchelnelson
Related Note: 1475966975985 1
Rationale for change

the MAJOR underlying mechanism of type 2b familial dyslipidemia is increased hepatic production of apoB(100)-containing lipoproteins, not necessarily "defective LDL receptors" (that's 2a)

https://doi.org/10.1016/j.jacc.2018.05.044
https://doi.org/10.1016/j.jacc.2022.01.010
https://doi.org/10.1161/CIR.0000000000000297

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::Step::190 #AK_Step1_v12::#OME::PreClinical::Biochemistry #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Biochemistry::Metabolism #AK_Step1_v12::#Pixorize::01_Biochemistry::23_Dyslipidemias_(deprecated)::03_Hypercholesterolemia #AK_Step1_v12::#FirstAid::01_Biochem::06_Metabolism::48_Familial_dyslipidemias::*Type_2_Hypercholesterolemia::Type_2A #AK_Other::^EXPN::Uworld #AK_Other::Only_Step_1 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#Bootcamp::Biochemistry::09_Lipid_Metabolism::10_Familial_Dyslipidemias #AK_Step1_v12::#UWorld::#UWSA2 #AK_Step1_v12::#AMBOSS::uiapt4 #AK_Step1_v12::#Pixorize::01_Biochemistry::04_Lipids::06_Familial_Hypercholesterolemia #AK_Other::AnKing_Image::!Subjects::Cardiology::Inherited_Hyperlipoproteinemia #AK_Other::AnKing_Image::MS::Inherited_Hyperlipoproteinemias #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::03_Pathology::13_Hyperlipidemia #AK_Step1_v12::#UWorld::Step::6442 #AK_Other::^EXPN::BGedit #AK_Step1_v12::#NBME::Free120::2024 #AK_Step1_v12::^Systems::Biochem::metabolism::fat